Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit-Reference-Cited by-同舟云学术

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit

Published:2021-04-27 Issue:16 Volume:325 Page:1620
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

,Sadeghipour Parham¹²,Talasaz Azita H.³,Rashidi Farid⁴,Sharif-Kashani Babak⁵⁶,Beigmohammadi Mohammad Taghi⁷,Farrokhpour Mohsen⁸,Sezavar Seyed Hashem⁹,Payandemehr Pooya¹⁰,Dabbagh Ali¹¹,Moghadam Keivan Gohari¹²,Jamalkhani Sepehr¹³,Khalili Hossein¹⁴,Yadollahzadeh Mahdi⁸,Riahi Taghi¹⁵,Rezaeifar Parisa⁴,Tahamtan Ouria⁴,Matin Samira⁴,Abedini Atefeh¹⁶,Lookzadeh Somayeh¹⁶,Rahmani Hamid¹⁷,Zoghi Elnaz¹⁸,Mohammadi Keyhan¹⁸,Sadeghipour Pardis⁸,Abri Homa⁸,Tabrizi Sanaz¹⁵,Mousavian Seyed Masoud¹⁵,Shahmirzaei Shaghayegh¹⁰,Bakhshandeh Hooman²¹⁹,Amin Ahmad¹⁹,Rafiee Farnaz¹⁹,Baghizadeh Elahe¹⁹,Mohebbi Bahram¹,Parhizgar Seyed Ehsan¹⁹,Aliannejad Rasoul²⁰²¹,Eslami Vahid²²,Kashefizadeh Alireza²³,Kakavand Hessam¹⁸,Hosseini Seyed Hossein¹⁸,Shafaghi Shadi⁶,Ghazi Samrand Fattah⁷,Najafi Atabak¹⁰,Jimenez David²⁴²⁵²⁶,Gupta Aakriti²⁷²⁸²⁹,Madhavan Mahesh V.²⁷²⁸,Sethi Sanjum S.²⁷²⁸,Parikh Sahil A.²⁷²⁸,Monreal Manuel³⁰,Hadavand Naser¹⁹,Hajighasemi Alireza³,Maleki Majid¹⁹,Sadeghian Saeed³,Piazza Gregory³¹,Kirtane Ajay J.²⁷²⁸,Van Tassell Benjamin W.³²³³,Dobesh Paul P.³⁴,Stone Gregg W.²⁷³⁵,Lip Gregory Y. H.³⁶³⁷,Krumholz Harlan M.²⁹³⁸³⁹,Goldhaber Samuel Z.³¹,Bikdeli Behnood²⁷²⁹³¹

Affiliation:

1. Cardiovascular Intervention Research Center, Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Tehran, Iran

2. Clinical Trial Center, Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Tehran, Iran

3. Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran

4. Tuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

5. Tobacoo Prevention and control Research center, National Research institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

6. Lung Transplantation Research Center, Department of Cardiology, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

7. Anesthesiology and Intensive Care, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

8. Firouzgar hospital, Department of internal medicine, Iran University of Medical Sciences, Tehran, Iran

9. Research Center for Prevention of Cardiovascular Disease, Institute of Endocrinology & Metabolism, Iran University of Medical Sciences, Tehran, Iran

10. Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

11. Department of Anesthesiology, School of Medicine Anesthesiology Research Center Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

12. School of Medicine, Department of Internal Medicine, Shariati Hospital, Tehran, Iran

13. Student Research Committee, Iran University of Medical Sciences, Tehran, Iran

14. Department of Pharmacotherapy, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

15. Rasoul-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran

16. Chronic Respiratory Disease Research Center, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

17. Department of Pharmacotherapy, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran

18. School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

19. Rajaie Cardiovascular Medical and Research Center, Iran university of Medical sciences, Tehran, Iran

20. School of Medicine, Department of Pulmonary and Critical Care, Shariati Hospital, Tehran, Iran

21. Advanced Thoracic Research Center, Tehran University of Medical Sciences, Tehran, Iran

22. Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

23. Shahid Dr Labbafinejad Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

24. Respiratory Department, Hospital Ramón y Cajal (IRYCIS), Madrid, Spain

25. Medicine Department, Universidad de Alcalá (IRYCIS), Madrid, Spain

26. CIBER Enfermedades Respiratorias (CIBERES), Madrid, Spain

27. Cardiovascular Research Foundation (CRF), New York, New York

28. Division of Cardiology, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, New York

29. Yale/YNHH Center for Outcomes Research & Evaluation, New Haven, Connecticut

30. Department of Internal Medicine, Hospital Germans Trias i Pujol, Badalona, Barcelona, Universidad Católica de Murcia, Murcia, Spain

31. Cardiovascular Medicine Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

32. School of Pharmacy, Department of Pharmacotherapy and Outcome Science, Virginia Commonwealth University, Richmond, Virginia

33. School of Pharmacy, Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia

34. College of Pharmacy, University of Nebraska Medical Center, Omaha

35. The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York

36. Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom

37. Aalborg University, Aalborg, Denmark

38. Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut

39. Department of Health Policy and Administration, Yale School of Public Health, New Haven, Connecticut

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2777829/jama_sadeghipour_2021_oi_210030_1618595330.70147.pdf

Reference38 articles.

1. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19.;Ackermann;N Engl J Med,2020

2. Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study.;Wichmann;Ann Intern Med,2020

3. COVID-19 is, in the end, an endothelial disease.;Libby;Eur Heart J,2020

4. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: jacc state-of-the-art review.;Bikdeli;J Am Coll Cardiol,2020

5. Thrombosis in hospitalized patients with COVID-19 in a New York City health system.;Bilaloglu;JAMA,2020

Cited by 507 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19;JACC: Advances;2024-03

2. Therapeutic-Dose Anticoagulation in Hospitalized Patients With COVID-19;JACC: Advances;2024-03

3. Effect of antiplatelet therapy after COVID-19 diagnosis: A systematic review with meta-analysis and trial sequential analysis;PLOS ONE;2024-02-01

4. Uncertainties about the roles of anticoagulation and microclots in post-acute sequelae of SARS-CoV-2 infection—response to the letter by Kell et al.;Journal of Thrombosis and Haemostasis;2024-02

5. Uncertainties about the roles of anticoagulation and microclots in postacute sequelae of SARS-CoV-2 infection: comment from Kell et al.;Journal of Thrombosis and Haemostasis;2024-02